These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22134481)

  • 21. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
    Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
    Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study.
    Usvasalo A; Savola S; Räty R; Vettenranta K; Harila-Saari A; Koistinen P; Savolainen ER; Elonen E; Saarinen-Pihkala UM; Knuutila S
    Leuk Res; 2008 Aug; 32(8):1228-35. PubMed ID: 18328560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
    Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
    Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
    J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.
    Zhang W; Kuang P; Liu T
    Ann Med; 2019 Feb; 51(1):28-40. PubMed ID: 30592434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.
    Dijkman R; Tensen CP; Jordanova ES; Knijnenburg J; Hoefnagel JJ; Mulder AA; Rosenberg C; Raap AK; Willemze R; Szuhai K; Vermeer MH
    J Clin Oncol; 2006 Jan; 24(2):296-305. PubMed ID: 16330669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
    Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of CDKN2A, CDKN2B and MTAP in childhood B-lineage acute lymphobastic leukemia.
    Beverloo HB
    Haematologica; 2006 Jul; 91(7):865B. PubMed ID: 16818264
    [No Abstract]   [Full Text] [Related]  

  • 31. New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia.
    Martinelli G; Iacobucci I; Soverini S; Piccaluga PP; Cilloni D; Pane F
    Expert Rev Hematol; 2009 Jun; 2(3):297-303. PubMed ID: 21082971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia.
    Boer JM; Steeghs EM; Marchante JR; Boeree A; Beaudoin JJ; Beverloo HB; Kuiper RP; Escherich G; van der Velden VH; van der Schoot CE; de Groot-Kruseman HA; Pieters R; den Boer ML
    Oncotarget; 2017 Jan; 8(3):4618-4628. PubMed ID: 27894077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.
    Guillaume N; Penther D; Vaida I; Gruson B; Harrivel V; Claisse JF; Capiod JC; Lefrere JJ; Damaj G
    Int J Lab Hematol; 2011 Feb; 33(1):92-6. PubMed ID: 20666852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement.
    Baeumler J; Szuhai K; Falkenburg JH; van Schie ML; Ottmann OG; Nijmeijer BA
    Cancer Genet Cytogenet; 2008 Aug; 185(1):37-42. PubMed ID: 18656692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G
    Leukemia; 2010 Jan; 24(1):66-73. PubMed ID: 19759560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
    Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
    Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
    J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.